<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04773002</url>
  </required_header>
  <id_info>
    <org_study_id>21-KAEK-067</org_study_id>
    <nct_id>NCT04773002</nct_id>
  </id_info>
  <brief_title>A Comparison of Volatile Anesthesia and Total Intravenous Anesthesia (TIVA)</brief_title>
  <official_title>A Comparison of Volatile Anesthesia and Total Intravenous Anesthesia (TIVA) on Ecchymosis, Edema, and Intraoperative Bleeding in Rhinoplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tokat Gaziosmanpasa University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tokat Gaziosmanpasa University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, investigators wanted to investigate the effect of volatile anesthesia and&#xD;
      total intravenous anesthesia (TIVA) on ecchymosis, edema, and intraoperative bleeding in&#xD;
      rhinoplasty.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Routine monitorization (blood pressure, pulse, oxygen saturation with pulse oximetry and&#xD;
      electrocardiogram) will be applied to all patients taken into the operation room.&#xD;
&#xD;
      In Group P (TIVA), induction of anesthesia will be achieved with 2 mg/kg propofol, 0.6 mg/kg&#xD;
      rocuronium, and 1 μ / kg fentanyl. Propofol and remifentanil will be used in the continuation&#xD;
      of anesthesia.&#xD;
&#xD;
      In Group S (Volatile), anesthesia will be induced with 2 mg / kg propofol, 0.6 mg / kg&#xD;
      rocuronium and 1 μ / kg fentanyl. 50% nitrous oxide + 50% oxygen and 2% sevoflurane will be&#xD;
      used in the continuation of anesthesia.&#xD;
&#xD;
      All patients will receive 2 ml/kg/hour Ringer's lactate solution during the operation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 18, 2021</start_date>
  <completion_date type="Actual">August 21, 2021</completion_date>
  <primary_completion_date type="Actual">August 21, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>Edema and ecchymosis in rhinoplasty according to the type of anesthesia.</measure>
    <time_frame>one time in six months</time_frame>
    <description>It is evaluation developing edema and ecchymosis according to total intravenous anesthesia and volatile anesthesia in rhinoplasty.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">60</enrollment>
  <condition>Rhinoplasty</condition>
  <condition>Ecchymosis</condition>
  <condition>Edema</condition>
  <condition>Hemorrhage</condition>
  <arm_group>
    <arm_group_label>Group P</arm_group_label>
    <description>Total intravenous anesthesia (TIVA)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group S</arm_group_label>
    <description>Volatile anestesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Different anesthesia methods</intervention_name>
    <description>Total intravenous anesthesia (TIVA)and volatile anesthesia</description>
    <arm_group_label>Group P</arm_group_label>
    <arm_group_label>Group S</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Rhinoplasty patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Between 18 and 65 years&#xD;
&#xD;
          -  Planned to rhinoplasty&#xD;
&#xD;
          -  An American Society of Anesthesiologists score of 1 or 2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Steroid use&#xD;
&#xD;
          -  Patients with coagulation disorders, •Rejected to participation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Muzaffer Katar</last_name>
    <role>Study Chair</role>
    <affiliation>Gaziosmanpasa university</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gaziosmanpasa University</name>
      <address>
        <city>Tokat</city>
        <zip>60200</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>February 23, 2021</study_first_submitted>
  <study_first_submitted_qc>February 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 26, 2021</study_first_posted>
  <last_update_submitted>August 21, 2021</last_update_submitted>
  <last_update_submitted_qc>August 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tokat Gaziosmanpasa University</investigator_affiliation>
    <investigator_full_name>Hakan Tapar</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ecchymosis</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

